Wassil Jim
Insider CIK 1813798 · PCVX EVP, Chief Scientific Ofc, COO · ICVX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-10-05 | 2026-10-07 | 18,000 | — | $0 | 46,398 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-10-05 | 2026-10-07 | 18,000 | $86.74 | $1.56M | 145,435 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-10-05 | 2026-10-07 | 18,000 | $5.35 | $96.3K | 163,435 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-10-01 | 2026-10-02 | 2,250 | — | $0 | 64,398 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 95 | $57.09 | $5.4K | 145,435 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 2,155 | $56.65 | $122.1K | 145,530 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-10-01 | 2026-10-02 | 2,250 | $5.35 | $12.0K | 147,685 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-09 | 2026-09-09 | 1,334 | $59.52 | $79.4K | 145,435 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-09 | 2026-09-09 | 1,334 | $59.52 | $79.4K | 145,435 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-08 | 2026-09-09 | 5,459 | $60.36 | $329.5K | 146,769 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-08 | 2026-09-09 | 5,459 | $60.36 | $329.5K | 146,769 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-04 | 2026-09-09 | 1,381 | $61.16 | $84.5K | 152,228 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-04 | 2026-09-09 | 1,381 | $61.16 | $84.5K | 152,228 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-02 | 2026-09-02 | 1,432 | $61.58 | $88.2K | 153,609 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-02 | 2026-09-02 | 1,432 | $61.58 | $88.2K | 153,609 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-09-01 | 2026-09-02 | 2,250 | — | $0 | 66,648 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-01 | 2026-09-02 | 924 | $60.96 | $56.3K | 155,344 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-01 | 2026-09-02 | 713 | $61.48 | $43.8K | 156,268 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-01 | 2026-09-02 | 1,537 | $60.89 | $93.6K | 156,981 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-09-01 | 2026-09-02 | 2,250 | $5.35 | $12.0K | 158,518 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-01 | 2026-09-02 | 303 | $61.42 | $18.6K | 155,041 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-09-01 | 2026-09-02 | 2,250 | — | $0 | 66,648 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-01 | 2026-09-02 | 303 | $61.42 | $18.6K | 155,041 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-01 | 2026-09-02 | 924 | $60.95 | $56.3K | 155,344 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-01 | 2026-09-02 | 713 | $61.48 | $43.8K | 156,268 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-09-01 | 2026-09-02 | 1,537 | $60.89 | $93.6K | 156,981 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-09-01 | 2026-09-02 | 2,250 | $5.35 | $12.0K | 158,518 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-08-31 | 2026-09-02 | 1,273 | $60.74 | $77.3K | 156,268 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-08-31 | 2026-09-02 | 1,273 | $60.74 | $77.3K | 156,268 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-08-03 | 2026-08-05 | 2,250 | — | $0 | 68,898 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 1,389 | $54.09 | $75.1K | 157,541 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 861 | $53.50 | $46.1K | 158,930 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-08-03 | 2026-08-05 | 2,250 | $5.35 | $12.0K | 159,791 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-08-03 | 2026-08-05 | 2,250 | — | $0 | 68,898 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 1,389 | $54.09 | $75.1K | 157,541 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 861 | $53.50 | $46.1K | 158,930 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-08-03 | 2026-08-05 | 2,250 | $5.35 | $12.0K | 159,791 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-06 | 516 | — | $0 | 71,148 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-01 | 2026-07-06 | 1,788 | $56.03 | $100.2K | 157,222 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-01 | 2026-07-06 | 456 | $57.47 | $26.2K | 156,766 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-01 | 2026-07-06 | 6 | $57.82 | $347 | 156,760 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-07-01 | 2026-07-06 | 516 | $5.35 | $2.8K | 159,010 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-01 | 2026-06-03 | 301 | $50.26 | $15.1K | 158,494 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-01 | 2026-06-03 | 1,949 | $49.40 | $96.3K | 158,795 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-05-01 | 2026-05-01 | 2,250 | $56.83 | $127.9K | 160,744 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 1,412 | $58.14 | $82.1K | 165,406 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 838 | $58.93 | $49.4K | 162,994 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-03-10 | 2026-03-11 | 2,427 | $58.32 | $141.5K | 171,786 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-03-10 | 2026-03-11 | 4,968 | $59.16 | $293.9K | 166,818 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-03-09 | 2026-03-11 | 975 | $59.32 | $57.8K | 174,213 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-03-02 | 2026-03-02 | 1,009 | $61.98 | $62.5K | 175,188 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-02-28 | 2026-03-02 | 898 | $61.98 | $55.7K | 176,197 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2026-02-27 | 2026-03-02 | 5,102 | $61.74 | $315.0K | 178,995 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-02-27 | 2026-03-02 | 1,900 | $61.74 | $117.3K | 177,095 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2026-02-26 | 2026-03-02 | 53,566 | — | $0 | 53,566 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2026-02-26 | 2026-03-02 | 32,045 | — | $0 | 173,893 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-08 | 2025-09-10 | 2,759 | $32.41 | $89.4K | 141,848 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 1,429 | $31.56 | $45.1K | 146,270 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 1,587 | $31.56 | $50.1K | 147,699 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 1,270 | $31.56 | $40.1K | 149,286 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-03-03 | 2025-03-03 | 2,638 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-03-03 | 2025-03-03 | 5,362 | — | $0 | 71,664 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-03-03 | 2025-03-03 | 3,015 | $72.10 | $217.4K | 151,916 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-03-03 | 2025-03-03 | 2,085 | $73.84 | $154.0K | 154,931 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-03-03 | 2025-03-03 | 5,915 | $73.07 | $432.2K | 157,016 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-03-03 | 2025-03-03 | 5,362 | $5.35 | $28.7K | 162,931 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-03-03 | 2025-03-03 | 2,638 | $2.42 | $6.4K | 157,569 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-02-28 | 2025-03-03 | 1,270 | $73.02 | $92.7K | 154,931 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-02-28 | 2025-03-03 | 2,869 | $73.02 | $209.5K | 156,201 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2025-02-28 | 2025-03-03 | 5,649 | $73.02 | $412.5K | 159,070 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2025-02-27 | 2025-03-03 | 72,536 | — | $0 | 72,536 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2025-02-27 | 2025-03-03 | 21,726 | — | $0 | 153,421 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-02-03 | 2025-02-04 | 8,000 | — | $0 | 2,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 5,314 | $86.00 | $457.0K | 208,381 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 2,666 | $86.67 | $231.1K | 205,715 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 20 | $87.94 | $1.8K | 205,695 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-02-03 | 2025-02-04 | 8,000 | $2.42 | $19.4K | 213,695 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-01-02 | 2025-01-03 | 8,000 | — | $0 | 10,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 1,161 | $84.43 | $98.0K | 205,695 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-01-02 | 2025-01-03 | 8,000 | $2.42 | $19.4K | 213,695 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 1,356 | $82.88 | $112.4K | 212,339 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 5,483 | $83.69 | $458.9K | 206,856 | SEC↗ |
| PCVX Vaxcyte, Inc. | G Gift | 2024-12-31 | 2025-03-03 | 74,000 | — | $0 | 131,695 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-12-02 | 2024-12-03 | 8,000 | — | $0 | 18,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-02 | 2024-12-03 | 1,101 | $93.06 | $102.5K | 206,822 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-02 | 2024-12-03 | 5,772 | $92.07 | $531.4K | 207,923 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-12-02 | 2024-12-03 | 8,000 | $2.42 | $19.4K | 213,695 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-02 | 2024-12-03 | 1,127 | $94.06 | $106.0K | 205,695 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-11-07 | 2024-11-08 | 35,661 | — | $0 | 35,661 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-11-07 | 2024-11-08 | 87,481 | — | $0 | 87,481 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-11-01 | 2024-11-04 | 8,000 | — | $0 | 26,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-01 | 2024-11-04 | 2,174 | $107.20 | $233.1K | 206,566 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-11-01 | 2024-11-04 | 8,000 | $2.42 | $19.4K | 213,695 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-01 | 2024-11-04 | 4,955 | $106.34 | $526.9K | 208,740 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-01 | 2024-11-04 | 631 | $108.25 | $68.3K | 205,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-01 | 2024-11-04 | 240 | $108.93 | $26.1K | 205,695 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-28 | 2024-10-29 | 3,464 | — | $0 | 89,876 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-28 | 2024-10-29 | 1,585 | — | $0 | 77,026 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-28 | 2024-10-29 | 3,464 | $20.93 | $72.5K | 205,695 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-28 | 2024-10-29 | 1,585 | $5.35 | $8.5K | 202,231 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-03 | 8,000 | — | $0 | 34,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-01 | 2024-10-03 | 8,000 | $2.42 | $19.4K | 208,646 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 2,312 | $113.42 | $262.2K | 206,334 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 3,349 | $114.32 | $382.9K | 202,985 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 2,339 | $114.95 | $268.9K | 200,646 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-09-16 | 2024-09-18 | 10,000 | — | $0 | 42,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-16 | 2024-09-18 | 222 | $116.96 | $26.0K | 200,646 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-09-16 | 2024-09-18 | 10,000 | $2.42 | $24.2K | 211,958 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-16 | 2024-09-18 | 1,784 | $115.06 | $205.3K | 210,174 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-16 | 2024-09-18 | 7,994 | $116.14 | $928.4K | 202,180 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-09-03 | 2024-09-05 | 10,000 | — | $0 | 52,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 389 | $114.25 | $44.4K | 209,052 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 2,072 | $110.08 | $228.1K | 215,173 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-09-03 | 2024-09-05 | 10,000 | $2.42 | $24.2K | 217,503 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-09-03 | 2024-09-05 | 5,545 | $110.15 | $610.8K | 201,958 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 10 | $117.03 | $1.2K | 207,503 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 1,195 | $116.42 | $139.1K | 207,513 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 344 | $115.15 | $39.6K | 208,708 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 258 | $108.01 | $27.9K | 217,245 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 367 | $112.95 | $41.5K | 209,441 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 2,263 | $111.85 | $253.1K | 209,808 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 3,102 | $111.02 | $344.4K | 212,071 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-08-01 | 2024-08-05 | 23 | $79.47 | $1.8K | 207,503 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-08-01 | 2024-08-05 | 2,977 | $78.84 | $234.7K | 207,526 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 1,226 | $75.75 | $92.9K | 212,277 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 1,663 | $76.71 | $127.6K | 210,614 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 111 | $77.22 | $8.6K | 210,503 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 460 | $73.48 | $33.8K | 213,503 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 1,634 | $71.38 | $116.6K | 214,869 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 906 | $72.32 | $65.5K | 213,964 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 185 | $63.65 | $11.8K | 215,462 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 1,062 | $61.99 | $65.8K | 215,647 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 1,753 | $61.23 | $107.3K | 216,709 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-04-17 | 2024-04-19 | 3,551 | — | $0 | 78,611 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-04-17 | 2024-04-19 | 3,551 | $5.35 | $19.0K | 221,840 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 677 | $67.23 | $45.5K | 218,289 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 2,323 | $66.53 | $154.5K | 218,966 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-03-15 | 2024-03-19 | 1,484 | $69.70 | $103.4K | 221,289 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2024-03-15 | 2024-03-19 | 4,099 | — | $0 | 222,773 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-03-02 | 2024-03-04 | 2,178 | $71.55 | $155.8K | 218,674 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 1,220 | $73.62 | $89.8K | 221,615 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 763 | $74.70 | $57.0K | 220,852 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 1,017 | $73.08 | $74.3K | 222,835 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-02-29 | 2024-03-04 | 90,000 | — | $0 | 90,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2024-02-29 | 2024-03-04 | 20,000 | — | $0 | 223,852 | SEC↗ |
| ICVX Icosavax, Inc. | D To issuer deriv | 2024-02-19 | 2024-02-20 | 17,000 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | D To issuer deriv | 2024-02-19 | 2024-02-20 | 44,556 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | D To issuer | 2024-02-19 | 2024-02-20 | 7,392 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | U Tender | 2024-02-19 | 2024-02-20 | 3,695 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-02-15 | 2024-02-20 | 27,917 | — | $0 | 62,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-02-15 | 2024-02-20 | 27,917 | $2.42 | $67.6K | 203,852 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-02-01 | 2024-02-05 | 3,000 | — | $0 | 90,555 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-02-01 | 2024-02-05 | 3,000 | $2.42 | $7.3K | 178,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 1,056 | $73.35 | $77.5K | 177,352 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 467 | $74.14 | $34.6K | 176,885 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 950 | $75.28 | $71.5K | 175,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 527 | $72.18 | $38.0K | 178,408 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-01-02 | 2024-01-04 | 3,000 | — | $0 | 93,555 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 1,039 | $63.55 | $66.0K | 177,607 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-01-02 | 2024-01-04 | 3,000 | $2.42 | $7.3K | 178,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 289 | $62.71 | $18.1K | 178,646 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 1,562 | $64.29 | $100.4K | 176,045 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 110 | $65.15 | $7.2K | 175,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-12-01 | 2023-12-05 | 3,000 | — | $0 | 96,555 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-12-01 | 2023-12-05 | 3,000 | $2.42 | $7.3K | 178,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 1,067 | $51.46 | $54.9K | 177,868 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 1,933 | $52.51 | $101.5K | 175,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-11-01 | 2023-11-03 | 3,000 | — | $0 | 99,555 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-11-01 | 2023-11-03 | 3,000 | $2.42 | $7.3K | 178,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-11-01 | 2023-11-03 | 2,878 | $47.22 | $135.9K | 176,057 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-11-01 | 2023-11-03 | 122 | $48.12 | $5.9K | 175,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-10-12 | 2023-10-16 | 5,000 | — | $0 | 102,555 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-10-12 | 2023-10-16 | 5,000 | $2.42 | $12.1K | 175,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-10-02 | 2023-10-04 | 3,000 | — | $0 | 107,555 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 850 | $51.56 | $43.8K | 170,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-10-02 | 2023-10-04 | 3,000 | $2.42 | $7.3K | 173,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 1,542 | $49.69 | $76.6K | 172,393 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 608 | $50.74 | $30.8K | 171,785 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-09-22 | 2023-09-26 | 3,000 | — | $0 | 110,555 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-09-22 | 2023-09-26 | 3,000 | $2.42 | $7.3K | 170,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2023-09-05 | 2023-09-06 | 2,131 | $51.00 | $108.7K | 167,935 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-09-01 | 2023-09-06 | 3,000 | — | $0 | 113,555 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-09-01 | 2023-09-06 | 323 | $53.36 | $17.2K | 170,066 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-09-01 | 2023-09-06 | 2,677 | $52.75 | $141.2K | 170,389 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-09-01 | 2023-09-06 | 3,000 | $2.42 | $7.3K | 173,066 | SEC↗ |
| ICVX Icosavax, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2023-03-02 | 2023-03-03 | 1,189 | $41.49 | $49.3K | 169,026 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 135,000 | — | $0 | 135,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2023-03-01 | 2023-03-03 | 22,500 | — | $0 | 170,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-12-30 | 2023-01-04 | 42,000 | — | $0 | 42,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-12-23 | 2022-12-28 | 105,371 | — | $0 | 116,555 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-12-23 | 2022-12-28 | 105,371 | $2.42 | $255.0K | 147,715 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-10-17 | 2022-10-19 | 2,800 | — | $0 | 221,926 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-10-17 | 2022-10-19 | 1,926 | $25.91 | $49.9K | 42,344 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-10-17 | 2022-10-19 | 874 | $25.31 | $22.1K | 44,270 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-10-17 | 2022-10-19 | 2,800 | $2.42 | $6.8K | 45,144 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-09-19 | 2022-09-21 | 2,800 | — | $0 | 224,726 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-09-19 | 2022-09-21 | 120 | $26.56 | $3.2K | 42,344 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-09-19 | 2022-09-21 | 2,800 | $2.42 | $6.8K | 45,144 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-09-19 | 2022-09-21 | 2,680 | $26.09 | $69.9K | 42,464 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2022-09-02 | 2022-09-07 | 2,162 | $26.38 | $57.0K | 42,344 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-08-17 | 2022-08-19 | 2,800 | — | $0 | 227,526 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-08-17 | 2022-08-19 | 2,800 | $2.42 | $6.8K | 47,306 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-17 | 2022-08-19 | 2,800 | $25.15 | $70.4K | 44,506 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-07-01 | 2022-07-06 | 2,800 | — | $0 | 230,326 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-07-01 | 2022-07-06 | 2,800 | $22.00 | $61.6K | 44,506 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-07-01 | 2022-07-06 | 2,800 | $2.42 | $6.8K | 47,306 | SEC↗ |
| ICVX Icosavax, Inc. | A Award deriv | 2022-06-10 | 2022-06-14 | 44,556 | — | $0 | 44,556 | SEC↗ |
| ICVX Icosavax, Inc. | A Award | 2022-06-10 | 2022-06-14 | 11,087 | — | $0 | 11,087 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-04-18 | 2022-04-20 | 2,800 | — | $0 | 233,126 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-04-18 | 2022-04-20 | 2,800 | $23.98 | $67.1K | 42,944 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-04-18 | 2022-04-20 | 2,800 | $2.42 | $6.8K | 45,744 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-03-02 | 2022-03-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-03-02 | 2022-03-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2022-03-02 | 2022-03-04 | 25,000 | — | $0 | 42,944 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-02-24 | 2022-02-28 | 10,000 | — | $0 | 235,926 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-02-24 | 2022-02-28 | 10,000 | $2.42 | $24.2K | 27,944 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-02-24 | 2022-02-28 | 10,000 | $22.00 | $220.0K | 17,944 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2021-04-01 | 2021-04-06 | 93,340 | — | $0 | 93,340 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-02-22 | 2021-02-24 | 3,000 | — | $0 | 245,926 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-22 | 2021-02-24 | 1,199 | $26.43 | $31.7K | 18,182 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-02-22 | 2021-02-24 | 3,000 | $2.42 | $7.3K | 19,381 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-22 | 2021-02-24 | 1,801 | $26.99 | $48.6K | 16,381 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-01-20 | 2021-01-21 | 3,000 | — | $0 | 248,926 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-20 | 2021-01-21 | 3,000 | $25.50 | $76.5K | 16,381 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-01-20 | 2021-01-21 | 3,000 | $2.42 | $7.3K | 19,381 | SEC↗ |